Related Experiment Videos
Klinefelter's syndrome: historical background and development.
Southern Medical Journal
|September 1, 1986
Summary
Klinefelter's syndrome, initially viewed as an endocrine issue, is now recognized as a chromosomal disorder involving an extra X chromosome. Diagnosis is typically via buccal smear, with treatment including testosterone for androgen deficiency and surgery for gynecomastia.
Area of Science:
- Endocrinology
- Genetics
- Reproductive Medicine
Background:
- Klinefelter's syndrome was historically considered an endocrine disorder characterized by small testes, sterility, and gynecomastia.
- Early research postulated a second testicular hormone, which remains unisolated.
- The syndrome affects 1 in 500 to 1,000 male births.
Observation:
- The syndrome is now understood to be a chromosomal abnormality, with 80% of patients having an extra X chromosome.
- Diagnosis is most effectively achieved through a buccal smear.
- Key clinical features include small testes, sterility, elevated follicle-stimulating hormone, and often gynecomastia.
Findings:
- The primary finding is the chromosomal basis of Klinefelter's syndrome, specifically the presence of an extra X chromosome.
- Androgen deficiency is a common complication, necessitating testosterone replacement therapy.
- Gynecomastia presents a treatment challenge, addressed surgically due to malignancy risk and cosmetic concerns.
Implications:
- Reclassification from endocrine to chromosomal disorder impacts diagnostic and research approaches.
- Effective diagnosis via buccal smear allows for earlier intervention.
- Current treatments focus on managing hormonal imbalances and physical manifestations, improving patient outcomes.